Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2

ISSN Imprimir: 0893-9675
ISSN On-line: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2013007889
pages 471-483

Iron, Erythropoietic Stimulating Agents, and Anemia in Cancer

John W. Adamson
Clinical Professor of Medicine, University of California, VA San Diego Healthcare System MC 111E 3350 La Jolla Village Drive, San Diego, CA 92161


Anemia commonly accompanies malignancies in patients and may contribute to morbidity. Correction of the anemia with erythropoietic stimulating agents, while possible, may be associated with complications such as tumor progression and adverse cardiovascular events. This review examines the data behind these concerns and raises the strategy of using iron, alone, in the setting of cancer-associated anemia to reduce exposure to transfusions in these patients and to potentially improve their quality of life.

Articles with similar content:

Cancer and Cancer Stem Cells: New Molecular Perspectives
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 1
Onur Sahin, Gokce Ceren Kuscu, Gulperi Oktem, Elif Tunc, Funda Cagirir Dindaroglu, Cevik Gurel, Ismet Hortu, Gizem Inetas, Aylin Buhur
Current State of Immunosuppression: Past, Present, and Future
Critical Reviews™ in Eukaryotic Gene Expression, Vol.25, 2015, issue 2
Ravinder K. Wali, Sabine Karam
From Targets to Targeted Therapies in Hepatocellular Carcinoma
Forum on Immunopathological Diseases and Therapeutics, Vol.5, 2014, issue 3-4
Melchiorre Cervello, Antonella Cusimano, Maria Rita Emma, Antonina Azzolina, Giuseppa Augello, James A. McCubrey, Daniele Balasus
Black Tea Extract Can Modulate Protein Expression of H-ras, c-Myc, p53, and Bcl-2 Genes During Pulmonary Hyperplasia, Dysplasia, and Carcinoma In Situ
Journal of Environmental Pathology, Toxicology and Oncology, Vol.24, 2005, issue 3
Sarmistha Banerjee, Chinmay K. Panda, Sugata Manna, Prosenjit Saha, Chaiti Ganguly, Sukta Das
Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 2
Jack R. Wands, Evan J. Walker, Stephen A. Rosenberg, Miran Kim